View of Adverse Event Label Expansion for GLP-1 Medications Due to Off-Label Use: Regulatory Implications and Challenges

Back to article IJBAS Adverse Event Label Expansion for GLP-1 Medications Due to Off-Label Use: Regulatory Implications and Challenges Download Download PDF